The MOGA type of protein involved in cell adhesion. Present throughout myelin sheaths. Project’s Research for Rare program has awarded our 2023 MOGADOften referred to as MOGAD, Anti-MOG, MOG Ab+, MOG Antibody Disease, MOG Associated Antibody Disease, MOG positive disease global research Apollo Grant. This particular grant provides funding to develop hypotheses and gather seed/pilot data to support and strengthen the submission of a future same subject proposal allowing investigators to better secure greater funding from larger organizations. Our grants are intended to support the advancement of medical knowledge and understanding of this rare disease leading to better diagnosis, targeted treatments, and eventually a cure.
Congratulations to our Apollo Grant recipients:
- Dr. Fabienne Brilot, Ph.D. - Kid's Neuroscience Centre and University of Sydney
- Dr. Stephen D. Miller, Ph.D. – Feinberg School of Medicine, Northwestern University
Special thanks to our SRO and Scientific Advisory Board Member, Dr. Lisa K. Ryan, Ph.D, and The MOGA type of protein involved in cell adhesion. Present throughout myelin sheaths. Project President, Amy Ednie, for leading this award cycle.
The MOGA type of protein involved in cell adhesion. Present throughout myelin sheaths. Project is a 501(c)3 nonprofit organization dedicated to funding researchers as part of our mission for the advancement of understanding, predicting, treating, and eventually curing Myelin Oligodendrocyte Glycoprotein Antibody DiseaseOften referred to as MOGAD, Anti-MOG, MOG Ab+, MOG Antibody Disease, MOG Associated Antibody Disease, MOG positive disease , or MOGADOften referred to as MOGAD, Anti-MOG, MOG Ab+, MOG Antibody Disease, MOG Associated Antibody Disease, MOG positive disease , a neuroinflammatory condition that attacks the optic nerveThe cranial nerves that relay messages from your eyes to your brain to create visual images. These nerves extend from the retina in the back of the eyes to the part of the brain that processes what we see. In myelin oligodendrocyte glycoproten antibody disease (MOGAD), they may be the target of inflammation or lesions, sometimes causing visual disruption or blindness., brain, and/or spinal column. For more information visit The MOG Project.
